HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Nature

• Publication date

  1992-12-03

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/360474A0PMID 1448172
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad.

  1992cited by this paper
• Irreversible association of peptides with class II MHC molecules in living cells

  1992cited by this paper
• Inhibition of endosomal proteolytic activity by leupeptin blocks surface expression of MHC class II molecules and their conversion to SDS resistance alpha beta heterodimers in endosomes.

  1992cited by this paper
• The antigen-processing mutant T2 suggests a role for MHC-linked genes in class II antigen presentation.

  1992cited by this paper
• HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides

  1992cited by this paper
• Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size

  1992cited by this paper
• Binding of a major T cell epitope of mycobacteria to a specific pocket within HLA‐DRw17(DR3) molecules

  1992cited by this paper
• Invariant chain targets HLA class II molecules to acidic endosomes containing internalized influenza virus.

  1991cited by this paper
• MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding

  1991cited by this paper
• Sequence analysis of peptides bound to MHC class II molecules

  1991cited by this paper
• A role for peptide in determining MHC class II structure

  1991cited by this paper
• A gene required for class II-restricted antigen presentation maps to the major histocompatibility complex

  1991cited by this paper
• Liposome-encapsulated antigens are processed in lysosomes, recycled, and presented to T cells.

  1991cited by this paper
• Proteolysis of the class II-associated invariant chain generates a peptide binding site in intracellular HLA-DR molecules.

  1991cited by this paper
• Defective processing and presentation of exogenous antigens in mutants with normal HLA class II genes

  1990cited by this paper
• Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding

  1990cited by this paper
• MHC class II-associated invariant chain contains a sorting signal for endosomal compartments.

  1990cited by this paper
• Regulation of antigen presentation by acidic pH

  1990cited by this paper
• Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways

  1990cited by this paper
• Intracellular transport of class II MHC molecules directed by invariant chain

  1990cited by this paper
• Inhibition by leupeptin and antipain of the intracellular proteolysis of Ii.

  1989cited by this paper
• Role for intracellular proteases in the processing and transport of class II HLA antigens.

  1988cited by this paper
• Murine class II (Ia) molecules associate with human invariant chain.

  1987cited by this paper
• Alternative splicing and alternative initiation of translation explain the four forms of the Ia antigen‐associated invariant chain.

  1986cited by this paper
• Two populations of Ia-like molecules on a human B cell line.

  1980cited by this paper
• Purification of HLA-linked B lymphocyte alloantigens in immunologically active form by preparative sodium dodecyl sulfate-gel electrophoresis and studies on their subunit association.

  1977cited by this paper
• Human B cell alloantigens: separation from other membrane molecules by affinity chromatography

  1977cited by this paper
• Isolation and characterization of human B cell alloantigens.

  1976cited by this paper

• MHC Class II and Beyond: Complex Role of CD74 in Cancer

  2026cites this paper
• Defective removal of invariant chain peptides from MHC class II suppresses tumor antigen presentation and promotes tumor growth.

  2025cites this paper
• CD74 and Proteases: Impact of Location on Immune and Cellular Functions

  2025cites this paper
• Structural insights into human MHC-II association with invariant chain

  2024cites this paper
• Metatranscriptome of human lung microbial communities in a cohort of mechanically ventilated COVID-19 Omicron patients

  2023cites this paper
• Mechanism of Antigen Presentation and Specificity of Antibody Cross-Reactivity Elicited by an Oligosaccharide-Conjugate Cancer Vaccine

  2023cites this paper
• The MHC Class II Antigen-Processing and Presentation Pathway Is Dysregulated in Type 1 Diabetes.

  2023cites this paper
• Proteomic characterization of phagocytic primary human monocyte-derived macrophages

  2022cites this paper
• RL-MLZerD: Multimeric protein docking using reinforcement learning

  2022cites this paper
• The transmembrane domain and luminal C-terminal region independently support invariant chain trimerization and assembly with MHCII into nonamers

  2021cites this paper
• HLA Class II Presentation Is Specifically Altered at Elevated Temperatures in the B-Lymphoblastic Cell Line JY

  2021cites this paper
• Partnering for the major histocompatibility complex class II and antigenic determinant requires flexibility and chaperons.

  2021cites this paper
• Gene expression during THP-1 differentiation is influenced by vitamin D3 and not vibrational mechanostimulation

  2021cites this paper
• Human Hepatitis B Viral Infection Outcomes Are Linked to Naturally Occurring Variants of HLA-DOA That Have Altered Function

  2020cites this paper
• Transcriptome analysis of Brucella abortus S19∆per immunized mouse spleen revealed activation of MHC-I and MHC-II pathways

  2019cites this paper
• A Missing Switch in Peptide Exchange for MHC Class II Molecules

  2019cites this paper
• N-Octanoyl-Dopamine inhibits cytokine production in activated T-cells and diminishes MHC-class-II expression as well as adhesion molecules in IFNγ-stimulated endothelial cells

  2019cites this paper
• Understanding antigen processing in chickens using genome editing technology

  2019influential citation
• Defining HLA-II Ligand Processing and Binding Rules with Mass Spectrometry Enhances Cancer Epitope Prediction.

  2019cites this paper
• What to do with HLA-DO/H-2O two decades later?

  2019cites this paper
• MHC Molecules, T cell Receptors, Natural Killer Cell Receptors, and Viral Immunoevasins-Key Elements of Adaptive and Innate Immunity.

  2019cites this paper
• Mass spectrometry–based identification of MHC-bound peptides for immunopeptidomics

  2019cites this paper
• A personal retrospective on the mechanisms of antigen processing

  2019cites this paper
• Molecular engineering strategies for visualizing low-affinity protein complexes

  2019cites this paper
• Pulse-Chase Analysis for Studies of MHC Class II Biosynthesis, Maturation, and Peptide Loading.

  2019cites this paper
• On the structure-function of MHC class II molecules and how single amino acid polymorphisms could alter intracellular trafficking.

  2019cites this paper
• Selection of immunodominant epitopes during antigen processing is hierarchical.

  2019cites this paper
• Analysis of C-peptide-specific CD4+ T cells in the peripheral blood of people with type 1 diabetes

  2018cites this paper
• Macrophage migration inhibitory factor (MIF) but not its homologue D‐dopachrome tautomerase (D‐DT) promotes fibroblast motility in a CD44/CD74‐independent manner

  2017cites this paper
• Unraveling the structural basis for the unusually rich association of human leukocyte antigen DQ2.5 with class-II-associated invariant chain peptides

  2017cites this paper
• Expression of Cathepsin S in BCG converts it into a pro-apoptotic and highly immunogenic strain.

  2017cites this paper
• Role of Proteases in Tumor Immune Evasion

  2017cites this paper
• Dynamic Changes in the Intracellular Association of Selected Rab Small GTPases with MHC Class II and DM during Dendritic Cell Maturation

  2017cites this paper
• Characterization of antibody binding to swine leukocyte antigen class II

  2016cites this paper
• Human leukocyte Antigen-DM polymorphisms in autoimmune diseases

  2016cites this paper
• Effects of cannabinoid receptor deletion on bone marrow-derived dendritic cell subtype development, maturation and antigen loading on MHC class I

  2016cites this paper
• MHC class II complexes sample intermediate states along the peptide exchange pathway

  2016cites this paper
• Molecular mechanisms underlying pMHC-II recognition

  2016cites this paper
• Open Peer Review

  2016cites this paper
• Antigen Processing and Presentation Mechanisms in Myeloid Cells

  2016cites this paper
• A step-by-step overview of the dynamic process of epitope selection by major histocompatibility complex class II for presentation to helper T cells

  2016cites this paper
• Mechanistic understanding and significance of small peptides interaction with MHC class II molecules for therapeutic applications

  2016cites this paper
• The Thermodynamic Mechanism of Peptide

  2015cites this paper
• Peptide Association Reactions - Class II Evaluating the Role of HLA-DM in MHC

  2015cites this paper
• Arthritis as Susceptibility Locus for Autoimmune ) HLA-DQ ( RT 1-B Positional Identification of Bäcklund

  2015cites this paper
• Antigen Presentation, Autoantigens, and Immune Regulation in Multiple Sclerosis and Other Autoimmune Diseases

  2015cites this paper
• The Thermodynamic Mechanism of Peptide–MHC Class II Complex Formation Is a Determinant of Susceptibility to HLA-DM

  2015cites this paper
• Scope of the Thesis

  2015cites this paper
• An Analysis of MIF Structural Features that Control Functional Activation of CD74.

  2015cites this paper
• TAPBPR: a new player in the MHC class I presentation pathway.

  2015cites this paper
• Positional Identification of RT1-B (HLA-DQ) as Susceptibility Locus for Autoimmune Arthritis

  2015cites this paper
• Determinant of Susceptibility to HLA-DM MHC Class II Complex Formation Is a − The Thermodynamic Mechanism of Peptide

  2015cites this paper
• Evaluating the Role of HLA-DM in MHC Class II–Peptide Association Reactions

  2015cites this paper
• MMTV Superantigens Coerce an Unconventional Topology between the TCR and MHC Class II

  2014influential citation
• Chapter 7 – Antigen Processing and Presentation

  2014cites this paper
• The human‐specific invariant chain isoform Iip35 modulates Iip33 trafficking and function

  2014cites this paper
• The invariant chain p35 isoform promotes formation of nonameric complexes with MHC II molecules

  2014cites this paper
• Endo-lysosomal proteases in antigen presentation.

  2014cites this paper
• Cholesterol lowering drug may influence cellular immune response by altering MHC II function[S]

  2013cites this paper
• Inhibition of HLA-DM Mediated MHC Class II Peptide Loading by HLA-DO Promotes Self Tolerance

  2013cites this paper
• The immunopathogenesis of ankylosing spondylitis

  2013influential citation
• Pulse-chase analysis for studies of MHC class II biosynthesis, maturation, and peptide loading.

  2013cites this paper
• Exploring genome-wide datasets of MHC class II antigen presentation.

  2013cites this paper
• Presentation of Phagocytosed Antigens by MHC Class I and II

  2013cites this paper
• of HLA-DR in Lysosomes and Destruction of the HLA-DR -Chain.

  2013cites this paper
• MHC Class II Tetramers Made from Isolated Recombinant α and β Chains Refolded with Affinity-Tagged Peptides

  2013cites this paper
• Toward a Network Model of MHC Class II-Restricted Antigen Processing

  2013cites this paper
• Regulation of HLA-DR peptide occupancy by histone deacetylase inhibitors

  2013cites this paper
• MHC class II antigen presentation by dendritic cells regulated through endosomal sorting.

  2013cites this paper
• Pathways of antigen processing.

  2013cites this paper
• Antigen and superantigen presentation as defined by the MHCII-accessory proteins and associated-peptides

  2013cites this paper
• T cell immunity to Kaposi’s sarcoma-associated herpesvirus latent proteins

  2012cites this paper
• The endosome–lysosome pathway and information generation in the immune system

  2012cites this paper
• How HLA-DM works: recognition of MHC II conformational heterogeneity.

  2012cites this paper
• HLA-DO acts as a substrate mimic to inhibit HLA-DM by a competitive mechanism

  2012cites this paper
• Human invariant chain isoform p35 restores thymic selection and antigen presentation in CD74‐deficient mice

  2012cites this paper
• Crystal structure of the HLA-DM-HLA-DR1 complex defines mechanisms for rapid peptide selection.

  2012cites this paper
• The mechanism of HLA-DM induced peptide exchange in the MHC class II antigen presentation pathway.

  2012cites this paper
• Forced Expression of HLA-DM at the Surface of Dendritic Cells Increases Loading of Synthetic Peptides on MHC Class II Molecules and Modulates T Cell Responses

  2011cites this paper
• An Insertion Mutant in DQA1*0501 Restores Susceptibility to HLA-DM: Implications for Disease Associations

  2011cites this paper
• Conformational Lability in MHC II Proteins: A Dissertation

  2011cites this paper
• A Genome-wide multidimensional RNAi screen reveals pathways controlling MHC class II antigen presentation.

  2011cites this paper
• Structural Insights Into HLA-DM Mediated MHC II Peptide Exchange.

  2011cites this paper
• This information is current as Molecules and Modulates T Cell Responses of Synthetic Peptides on MHC Class II Surface of Dendritic Cells Increases Loading Forced Expression of HLA-DM at the

  2011cites this paper
• Structural Investigations of MHC Class II Conformers

  2011cites this paper
• A reductionist cell-free major histocompatibility complex class II antigen processing system identifies immunodominant epitopes

  2010cites this paper
• The role of idiotype-specific immunity in antigen receptor diversity

  2010influential citation
• Structural and Functional Studies of Proteins Involved in Antigen Processing: A Dissertation

  2010cites this paper
• A novel Minimalist Cell-Free MHC Class II Antigen Processing System Identifies Immunodominant Epitopes

  2010cites this paper
• HLA-DM Captures Partially Empty HLA-DR Molecules for Catalyzed Peptide Removal

  2010cites this paper
• In Vivo Enhancement of Peptide Display by MHC Class II Molecules with Small Molecule Catalysts of Peptide Exchange1

  2009cites this paper
• The immunodominance of CD4 T cell epitopes is peptide intrinsic: Implications for rational vaccine design

  2009influential citation
• Subtle Affinity-Enhancing Mutations in a Myelin Oligodendrocyte Glycoprotein-Specific TCR Alter Specificity and Generate New Self-Reactivity1

  2009cites this paper
• Role of MeCP2 in heterochromatin organization during differentiation and disease

  2009cites this paper
• Identification and characterization of peptide-like MHC- ligand exchange catalyst as immune response enhancer

  2009cites this paper
• Class II major histocompatibility complex tetramer staining: progress, problems, and prospects

  2008cites this paper
• Thèse de doctorat de l'Université Joseph Fourier-Grenoble I

  2008cites this paper
• Anchor Side Chains of Short Peptide Fragments Trigger Ligand-Exchange of Class II MHC Molecules

  2008cites this paper
• Allelic diversity at the primate MHC-DMB locus: presence of a conserved tyrosine inhibitory motif in the cytoplasmic tail.

  2008cites this paper
• Characterization of intracellular HLA-DR, DM and DO profile in K562 and HL-60 leukemic cells.

  2008cites this paper